Oncology Nursing Drug Handbook
2018 Oncology Nursing Drug Handbook. Written especially for nurses caring for patients with cancer. Download the FREE app and view selected topics (Approximately 10% of the content is viewable in the free app and tapping on the locked topic will launch the in-app purchase screen).
The 2018 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.
Completely revised and updated, the 2017 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs.
New drugs include: alectinib (Alecensa), atezolizumab (Tecentriq), cabozantinib tablets (Cabometyx), cabozantinib capsules (Cometriq), cobimetinib tablets (Cotellic), colistin/polymixin B, clotrimazole, daratumumab (Darzalex), elotuzumab (Empliciti), irinotecan liposome injection (Onivyde), ixazomib (Ninlaro), melphalan for injection (Evoela), necitumumab (Portrazza), osimertinib (Targrisso), pentamidine, posaconazole, peramivir, rolapitant (Varubi) , talimogene laherparepvec (Imlygic), Tamiflu, trabectedin (Yondelis), uridine triacetate (Vistogard granules), venetoclax (Venclexta), vincristine liposome injection (Marqibo), and zanamivir.
Table of Content:
I Cancer Treatment
1 Introduction to Chemotherapy Drugs
2 Biologic Response Modifier Therapy
3 Cytoprotective Agents
4 Molecularly Targeted Therapies
5 Chemobiotherapy for Noncancer Diseases
II Symptom Management
6 Pain
7 Nausea and Vomiting
8 Anorexia and Cachexia
9 Anxiety and Depression
III Complications
10 Managing Tumor-Related Skeletal Events and Hypercalcemia
11 Infection
12 Constipation
13 Diarrhea
Appendix 1 : Occupational Exposure to Hazardous Drugs
Appendix 2 :Common Terminology Criteria for Adverse Events (CTCAE)
Author:
Gail M. Wilkes, MS, APRN-BC, AOCN-Oncology Nursing Consultant, Kilauea, Hawaii
ISBN-13: 9781284117189
ISBN-10:1284117189
尤其是寫護士照顧病人患有癌症。
《腫瘤護理藥物手冊》是專門為護理癌症患者的護士編寫的，它在護理過程方面獨特地表達了藥物治療：護理診斷，毒性病因以及護理評估，干預和評估的要點。該基本參考資料每年更新一次，提供了有關有效症狀管理，患者教育和化療管理的寶貴信息。
完全修訂和更新的《腫瘤學護理藥物手冊》包括有關分子和免疫學/生物學靶向治療的單獨章節。這些章節提供了基本的評述，以幫助護士了解癌症干擾的細胞通訊途徑。它還提供簡化的內容，注意了解免疫檢查點抑製劑，有關免疫療法的新信息，新藥及其適應症以及最近FDA批准的藥物的適應症和副作用的更新。
新藥包括：
阿帕魯胺（Erleada™）
calaspargase pegol-mknl（Asparlas™）
注射用柔紅黴素和阿糖胞苷脂質體（Vyxeos®）
葡糖苷酶（Voraxaze®）
alpelisib（Piqray®）
比尼替尼（Mektovi®）
達可替尼（Vizimpro®）
Duvelisib（Copiktra®）
恩哥拉尼（Braftovi®）
erdafitinib（Balversa™）
氯雷替尼（Lorbrena®）
anakinra（Kineret®）
巴西替尼（Olumiant®）
sarilumab（Kevzara®）
瑞芬特注射劑（Cinvanti®）
鹽酸格拉司瓊緩釋注射液（Sustol®）
樂透水（Prevymis™）
奧馬環素（Nuzyra™）
美羅培南/ vaborbactam（Vabomere™）
Plazomicin（Zemdri™）
baloxavir marboxil（Xofluza™）
亞胺培南/西司他丁鈉/雷巴坦（Recarbrio™）
eravacycline（Xerava™）
地氟沙星（Baxdela™）